Please assess the completion status of the following clinical trial:

Trial Title: A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women greater than 18 years of age~* Undergoing primary elective valve surgery at Brigham and Women's Hospital~* Consented for Transesophogeal Echocardiography (TEE) as part of routine intra-operative care and monitoring~Exclusion Criteria:~* Patients not consented for TEE as part of routine intra-operative care~* Any absolute contraindication to TEE~* Ionized calcium level \< 0.80 mmol/L near separation from CPB~* Myocardial infarction (MI) or acute coronary syndromes \< 3 months prior to surgery due to the presence of pre-operative diastolic dysfunction in infarcted or ischemic myocardium~* Ejection fraction (EF) \< 35%~* Atrial fibrillation / flutter the absence of an A wave on mitral inflow Doppler~* Heart rate (HR) \> 100 during 2 data point collections due to E / A wave superimposition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Calcium Chloride (Type: ACTIVE_COMPARATOR): Calcium chloride, 10mg/kg
- Placebo (Type: PLACEBO_COMPARATOR): Normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).